BioScision Pharma Inc. is a biopharmaceutical development and manufacturing organization focused on producing cannabinoids, terpenes and flavonoids for the Canadian and international medical and adult-use markets using proprietary expression and purification processes.
member
Cubresa has installed the first BrainPET Insert System at St. Joseph’s Health Care London, in partnership with the hospital’s research institute – Lawson Health Research Institute.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.